APO Research
Talk to an analyst

APO RESEARCH · REPORT

Human Interleukin ELISA Kit

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Human Interleukin ELISA Kit Industry Growth and Trends Forecast to 2032

8 January 2026124 pages

Choose your research edition.

Industry ResearchHuman Interleukin ELISA Kit Industry Research Report 2026144 pages · $2,950 USDIndustry Growth & TrendsGlobal Human Interleukin ELISA Kit Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Human Interleukin ELISA Kit Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Human Interleukin ELISA Kit Market Outlook and Growth Opportunities 2026210 pages · $4,250 USDMarket Analysis & ForecastGlobal Human Interleukin ELISA Kit Market Analysis and Forecast 2026-2032215 pages · $4,950 USD

Market perspective

The global Human Interleukin ELISA Kit market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Human Interleukin ELISA Kit is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Human Interleukin ELISA Kit is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Human Interleukin ELISA Kit is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Human Interleukin ELISA Kit include Abcam, Mabtech AB, Aviva Systems Biology, G Biosciences, MD Bioproducts, OriGene Technologies, Eagle Bioscience, Novus Biologicals and Thermo Fisher Scientific, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Human Interleukin ELISA Kit market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Human Interleukin ELISA Kit market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Human Interleukin ELISA Kit market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Human Interleukin ELISA Kit.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Human Interleukin ELISA Kit market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Human Interleukin ELISA Kit Market by Company

Abcam

Mabtech AB

Aviva Systems Biology

G Biosciences

MD Bioproducts

OriGene Technologies

Eagle Bioscience

Novus Biologicals

Thermo Fisher Scientific

Enzo Life Sciences

BioLegend

DEMEDITEC Diagnostics

ScienCell Research Laboratories

Exreprotein

R&D Systems

Cell Sciences

AssayPro

BPS Bioscience

ACROBiosystems

Cayman Chemical

BosterBio

Bioassay Technology Laboratory

Kamiya Biomedical Company

Reddot Biotech

Krishgen Biosystems

RayBiotech

United States Biological

Sino Biological

CUSABIO Technology

Bioss

MyBioSource.com

BioVendor Laboratory Medicine

Abbexa

Fine Biotech

Biorbyt

Human Interleukin ELISA Kit Segment by Type

Sandwich ELISA

Competitive ELISA

Direct ELISA

Indirect ELISA

Human Interleukin ELISA Kit Segment by Application

Clinical Diagnosis

Drug Development

Human Interleukin ELISA Kit Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Human Interleukin ELISA Kit market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Human Interleukin ELISA Kit and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Human Interleukin ELISA Kit.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Human Interleukin ELISA Kit manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Human Interleukin ELISA Kit in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Sandwich ELISA Table 2. Major Company of Competitive ELISA Table 3. Major Company of Direct ELISA Table 4. Major Company of Indirect ELISA Table 5. Global Human Interleukin ELISA Kit Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 6. Global Human Interleukin ELISA Kit Sales by Type (2021-2026) & (k units) Table 7. Global Human Interleukin ELISA Kit Sales Market Share in Volume by Type (2021-2026) Table 8. Global Human Interleukin ELISA Kit Sales by Type (2021-2026) & (US$ Million) Table 9. Global Human Interleukin ELISA Kit Sales Market Share in Value by Type (2021-2026) Table 10. Global Human Interleukin ELISA Kit Price by Type (2021-2026) & (USD/unit) Table 11. Global Human Interleukin ELISA Kit Sales by Type (2027-2032) & (k units) Table 12. Global Human Interleukin ELISA Kit Sales Market Share in Volume by Type (2027-2032) Table 13. Global Human Interleukin ELISA Kit Sales by Type (2027-2032) & (US$ Million) Table 14. Global Human Interleukin ELISA Kit Sales Market Share in Value by Type (2027-2032) Table 15. Global Human Interleukin ELISA Kit Price by Type (2027-2032) & (USD/unit) Table 16. North America Human Interleukin ELISA Kit Sales by Type (2021-2026) & (k units) Table 17. North America Human Interleukin ELISA Kit Sales by Type (2021-2026) & (US$ Million) Table 18. Europe Human Interleukin ELISA Kit Sales by Type (2021-2026) & (k units) Table 19. Europe Human Interleukin ELISA Kit Sales by Type (2021-2026) & (US$ Million) Table 20. Asia-Pacific Human Interleukin ELISA Kit Sales by Type (2021-2026) & (k units) Table 21. Asia-Pacific Human Interleukin ELISA Kit Sales by Type (2021-2026) & (US$ Million) Table 22. Latin America Human Interleukin ELISA Kit Sales by Type (2021-2026) & (k units) Table 23. Latin America Human Interleukin ELISA Kit Sales by Type (2021-2026) & (US$ Million) Table 24. Middle East and Africa Human Interleukin ELISA Kit Sales by Type (2021-2026) & (k units) Table 25. Middle East and Africa Human Interleukin ELISA Kit Sales by Type (2021-2026) & (US$ Million) Table 26. Human Interleukin ELISA Kit Industry Trends Table 27. Human Interleukin ELISA Kit Industry Drivers Table 28. Human Interleukin ELISA Kit Industry Opportunities and Challenges Table 29. Human Interleukin ELISA Kit Industry Restraints Table 30. Global Human Interleukin ELISA Kit Sales Revenue by Company (US$ Million) & (2021-2026) Table 31. Global Human Interleukin ELISA Kit Revenue Market Share by Company (2021-2026) Table 32. Global Human Interleukin ELISA Kit Sales by Company (2021-2026) & (k units) Table 33. Global Human Interleukin ELISA Kit Sales Share by Company (2021-2026) Table 34. Global Human Interleukin ELISA Kit Market Price by Company (2021-2026) & (USD/unit) Table 35. Global Human Interleukin ELISA Kit Industry Company Ranking, 2024 VS 2025 VS 2026 Table 36. Global Human Interleukin ELISA Kit Major Company Production Sites and Headquarters Table 37. Global Human Interleukin ELISA Kit Company, Product Type & Application Table 38. Global Human Interleukin ELISA Kit Company Establishment Date Table 39. Global Company Market Concentration Ratio (CR5 and HHI) Table 40. Global Human Interleukin ELISA Kit by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 41. Global Human Interleukin ELISA Kit Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 42. Global Human Interleukin ELISA Kit Sales by Region (2021-2026) & (k units) Table 43. Global Human Interleukin ELISA Kit Sales Market Share in Volume by Region (2021-2026) Table 44. Global Human Interleukin ELISA Kit Sales by Region (2021-2026) & (US$ Million) Table 45. Global Human Interleukin ELISA Kit Sales Market Share in Value by Region (2021-2026) Table 46. Global Human Interleukin ELISA Kit Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 47. Global Human Interleukin ELISA Kit Sales by Region (2027-2032) & (k units) Table 48. Global Human Interleukin ELISA Kit Sales Market Share in Volume by Region (2027-2032) Table 49. Global Human Interleukin ELISA Kit Sales by Region (2027-2032) & (US$ Million) Table 50. Global Human Interleukin ELISA Kit Sales Market Share in Value by Region (2027-2032) Table 51. Global Human Interleukin ELISA Kit Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2027-2032) Table 52. Global Human Interleukin ELISA Kit Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 53. Global Human Interleukin ELISA Kit Sales by Application (2021-2026) & (k units) Table 54. Global Human Interleukin ELISA Kit Sales Market Share in Volume by Application (2021-2026) Table 55. Global Human Interleukin ELISA Kit Sales by Application (2021-2026) & (US$ Million) Table 56. Global Human Interleukin ELISA Kit Sales Market Share in Value by Application (2021-2026) Table 57. Global Human Interleukin ELISA Kit Price by Application (2021-2026) & (USD/unit) Table 58. Global Human Interleukin ELISA Kit Sales by Application (2027-2032) & (k units) Table 59. Global Human Interleukin ELISA Kit Sales Market Share in Volume by Application (2027-2032) Table 60. Global Human Interleukin ELISA Kit Sales by Application (2027-2032) & (US$ Million) Table 61. Global Human Interleukin ELISA Kit Sales Market Share in Value by Application (2027-2032) Table 62. Global Human Interleukin ELISA Kit Price by Application (2027-2032) & (USD/unit) Table 63. North America Human Interleukin ELISA Kit Sales by Application (2021-2026) & (k units) Table 64. North America Human Interleukin ELISA Kit Sales by Application (2021-2026) & (US$ Million) Table 65. Europe Human Interleukin ELISA Kit Sales by Application (2021-2026) & (k units) Table 66. Europe Human Interleukin ELISA Kit Sales by Application (2021-2026) & (US$ Million) Table 67. Asia-Pacific Human Interleukin ELISA Kit Sales by Application (2021-2026) & (k units) Table 68. Asia-Pacific Human Interleukin ELISA Kit Sales by Application (2021-2026) & (US$ Million) Table 69. Latin America Human Interleukin ELISA Kit Sales by Application (2021-2026) & (k units) Table 70. Latin America Human Interleukin ELISA Kit Sales by Application (2021-2026) & (US$ Million) Table 71. Middle East and Africa Human Interleukin ELISA Kit Sales by Application (2021-2026) & (k units) Table 72. Middle East and Africa Human Interleukin ELISA Kit Sales by Application (2021-2026) & (US$ Million) Table 73. Abcam Company Information Table 74. Abcam Business Overview Table 75. Abcam Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Abcam Human Interleukin ELISA Kit Product Portfolio Table 77. Abcam Recent Development Table 78. Mabtech AB Company Information Table 79. Mabtech AB Business Overview Table 80. Mabtech AB Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Mabtech AB Human Interleukin ELISA Kit Product Portfolio Table 82. Mabtech AB Recent Development Table 83. Aviva Systems Biology Company Information Table 84. Aviva Systems Biology Business Overview Table 85. Aviva Systems Biology Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Aviva Systems Biology Human Interleukin ELISA Kit Product Portfolio Table 87. Aviva Systems Biology Recent Development Table 88. G Biosciences Company Information Table 89. G Biosciences Business Overview Table 90. G Biosciences Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. G Biosciences Human Interleukin ELISA Kit Product Portfolio Table 92. G Biosciences Recent Development Table 93. MD Bioproducts Company Information Table 94. MD Bioproducts Business Overview Table 95. MD Bioproducts Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. MD Bioproducts Human Interleukin ELISA Kit Product Portfolio Table 97. MD Bioproducts Recent Development Table 98. OriGene Technologies Company Information Table 99. OriGene Technologies Business Overview Table 100. OriGene Technologies Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. OriGene Technologies Human Interleukin ELISA Kit Product Portfolio Table 102. OriGene Technologies Recent Development Table 103. Eagle Bioscience Company Information Table 104. Eagle Bioscience Business Overview Table 105. Eagle Bioscience Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Eagle Bioscience Human Interleukin ELISA Kit Product Portfolio Table 107. Eagle Bioscience Recent Development Table 108. Novus Biologicals Company Information Table 109. Novus Biologicals Business Overview Table 110. Novus Biologicals Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Novus Biologicals Human Interleukin ELISA Kit Product Portfolio Table 112. Novus Biologicals Recent Development Table 113. Thermo Fisher Scientific Company Information Table 114. Thermo Fisher Scientific Business Overview Table 115. Thermo Fisher Scientific Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Thermo Fisher Scientific Human Interleukin ELISA Kit Product Portfolio Table 117. Thermo Fisher Scientific Recent Development Table 118. Enzo Life Sciences Company Information Table 119. Enzo Life Sciences Business Overview Table 120. Enzo Life Sciences Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Enzo Life Sciences Human Interleukin ELISA Kit Product Portfolio Table 122. Enzo Life Sciences Recent Development Table 123. BioLegend Company Information Table 124. BioLegend Business Overview Table 125. BioLegend Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. BioLegend Human Interleukin ELISA Kit Product Portfolio Table 127. BioLegend Recent Development Table 128. DEMEDITEC Diagnostics Company Information Table 129. DEMEDITEC Diagnostics Business Overview Table 130. DEMEDITEC Diagnostics Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. DEMEDITEC Diagnostics Human Interleukin ELISA Kit Product Portfolio Table 132. DEMEDITEC Diagnostics Recent Development Table 133. ScienCell Research Laboratories Company Information Table 134. ScienCell Research Laboratories Business Overview Table 135. ScienCell Research Laboratories Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. ScienCell Research Laboratories Human Interleukin ELISA Kit Product Portfolio Table 137. ScienCell Research Laboratories Recent Development Table 138. Exreprotein Company Information Table 139. Exreprotein Business Overview Table 140. Exreprotein Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Exreprotein Human Interleukin ELISA Kit Product Portfolio Table 142. Exreprotein Recent Development Table 143. R&D Systems Company Information Table 144. R&D Systems Business Overview Table 145. R&D Systems Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. R&D Systems Human Interleukin ELISA Kit Product Portfolio Table 147. R&D Systems Recent Development Table 148. Cell Sciences Company Information Table 149. Cell Sciences Business Overview Table 150. Cell Sciences Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 151. Cell Sciences Human Interleukin ELISA Kit Product Portfolio Table 152. Cell Sciences Recent Development Table 153. AssayPro Company Information Table 154. AssayPro Business Overview Table 155. AssayPro Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 156. AssayPro Human Interleukin ELISA Kit Product Portfolio Table 157. AssayPro Recent Development Table 158. BPS Bioscience Company Information Table 159. BPS Bioscience Business Overview Table 160. BPS Bioscience Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 161. BPS Bioscience Human Interleukin ELISA Kit Product Portfolio Table 162. BPS Bioscience Recent Development Table 163. ACROBiosystems Company Information Table 164. ACROBiosystems Business Overview Table 165. ACROBiosystems Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 166. ACROBiosystems Human Interleukin ELISA Kit Product Portfolio Table 167. ACROBiosystems Recent Development Table 168. Cayman Chemical Company Information Table 169. Cayman Chemical Business Overview Table 170. Cayman Chemical Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 171. Cayman Chemical Human Interleukin ELISA Kit Product Portfolio Table 172. Cayman Chemical Recent Development Table 173. BosterBio Company Information Table 174. BosterBio Business Overview Table 175. BosterBio Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 176. BosterBio Human Interleukin ELISA Kit Product Portfolio Table 177. BosterBio Recent Development Table 178. Bioassay Technology Laboratory Company Information Table 179. Bioassay Technology Laboratory Business Overview Table 180. Bioassay Technology Laboratory Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 181. Bioassay Technology Laboratory Human Interleukin ELISA Kit Product Portfolio Table 182. Bioassay Technology Laboratory Recent Development Table 183. Kamiya Biomedical Company Company Information Table 184. Kamiya Biomedical Company Business Overview Table 185. Kamiya Biomedical Company Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 186. Kamiya Biomedical Company Human Interleukin ELISA Kit Product Portfolio Table 187. Kamiya Biomedical Company Recent Development Table 188. Reddot Biotech Company Information Table 189. Reddot Biotech Business Overview Table 190. Reddot Biotech Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 191. Reddot Biotech Human Interleukin ELISA Kit Product Portfolio Table 192. Reddot Biotech Recent Development Table 193. Krishgen Biosystems Company Information Table 194. Krishgen Biosystems Business Overview Table 195. Krishgen Biosystems Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 196. Krishgen Biosystems Human Interleukin ELISA Kit Product Portfolio Table 197. Krishgen Biosystems Recent Development Table 198. RayBiotech Company Information Table 199. RayBiotech Business Overview Table 200. RayBiotech Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 201. RayBiotech Human Interleukin ELISA Kit Product Portfolio Table 202. RayBiotech Recent Development Table 203. United States Biological Company Information Table 204. United States Biological Business Overview Table 205. United States Biological Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 206. United States Biological Human Interleukin ELISA Kit Product Portfolio Table 207. United States Biological Recent Development Table 208. Sino Biological Company Information Table 209. Sino Biological Business Overview Table 210. Sino Biological Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 211. Sino Biological Human Interleukin ELISA Kit Product Portfolio Table 212. Sino Biological Recent Development Table 213. CUSABIO Technology Company Information Table 214. CUSABIO Technology Business Overview Table 215. CUSABIO Technology Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 216. CUSABIO Technology Human Interleukin ELISA Kit Product Portfolio Table 217. CUSABIO Technology Recent Development Table 218. Bioss Company Information Table 219. Bioss Business Overview Table 220. Bioss Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 221. Bioss Human Interleukin ELISA Kit Product Portfolio Table 222. Bioss Recent Development Table 223. MyBioSource.com Company Information Table 224. MyBioSource.com Business Overview Table 225. MyBioSource.com Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 226. MyBioSource.com Human Interleukin ELISA Kit Product Portfolio Table 227. MyBioSource.com Recent Development Table 228. BioVendor Laboratory Medicine Company Information Table 229. BioVendor Laboratory Medicine Business Overview Table 230. BioVendor Laboratory Medicine Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 231. BioVendor Laboratory Medicine Human Interleukin ELISA Kit Product Portfolio Table 232. BioVendor Laboratory Medicine Recent Development Table 233. Abbexa Company Information Table 234. Abbexa Business Overview Table 235. Abbexa Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 236. Abbexa Human Interleukin ELISA Kit Product Portfolio Table 237. Abbexa Recent Development Table 238. Fine Biotech Company Information Table 239. Fine Biotech Business Overview Table 240. Fine Biotech Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 241. Fine Biotech Human Interleukin ELISA Kit Product Portfolio Table 242. Fine Biotech Recent Development Table 243. Biorbyt Company Information Table 244. Biorbyt Business Overview Table 245. Biorbyt Human Interleukin ELISA Kit Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 246. Biorbyt Human Interleukin ELISA Kit Product Portfolio Table 247. Biorbyt Recent Development Table 248. North America Human Interleukin ELISA Kit Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 249. North America Human Interleukin ELISA Kit Sales by Country (2021-2026) & (k units) Table 250. North America Human Interleukin ELISA Kit Sales Market Share by Country (2021-2026) Table 251. North America Human Interleukin ELISA Kit Sales Forecast by Country (2027-2032) & (k units) Table 252. North America Human Interleukin ELISA Kit Sales Market Share Forecast by Country (2027-2032) Table 253. North America Human Interleukin ELISA Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 254. North America Human Interleukin ELISA Kit Market Size by Country (2021-2026) & (US$ Million) Table 255. North America Human Interleukin ELISA Kit Market Share by Country (2021-2026) Table 256. North America Human Interleukin ELISA Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 257. North America Human Interleukin ELISA Kit Market Share Forecast by Country (2027-2032) Table 258. Europe Human Interleukin ELISA Kit Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 259. Europe Human Interleukin ELISA Kit Sales by Country (2021-2026) & (k units) Table 260. Europe Human Interleukin ELISA Kit Sales Market Share by Country (2021-2026) Table 261. Europe Human Interleukin ELISA Kit Sales Forecast by Country (2027-2032) & (k units) Table 262. Europe Human Interleukin ELISA Kit Sales Market Share Forecast by Country (2027-2032) Table 263. Europe Human Interleukin ELISA Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 264. Europe Human Interleukin ELISA Kit Market Size by Country (2021-2026) & (US$ Million) Table 265. Europe Human Interleukin ELISA Kit Market Share by Country (2021-2026) Table 266. Europe Human Interleukin ELISA Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 267. Europe Human Interleukin ELISA Kit Market Share Forecast by Country (2027-2032) Table 268. Asia-Pacific Human Interleukin ELISA Kit Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 269. Asia-Pacific Human Interleukin ELISA Kit Sales by Country (2021-2026) & (k units) Table 270. Asia-Pacific Human Interleukin ELISA Kit Sales Market Share by Country (2021-2026) Table 271. Asia-Pacific Human Interleukin ELISA Kit Sales Forecast by Country (2027-2032) & (k units) Table 272. Asia-Pacific Human Interleukin ELISA Kit Sales Market Share Forecast by Country (2027-2032) Table 273. Asia-Pacific Human Interleukin ELISA Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 274. Asia-Pacific Human Interleukin ELISA Kit Market Size by Country (2021-2026) & (US$ Million) Table 275. Asia-Pacific Human Interleukin ELISA Kit Market Share by Country (2021-2026) Table 276. Asia-Pacific Human Interleukin ELISA Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 277. Asia-Pacific Human Interleukin ELISA Kit Market Share Forecast by Country (2027-2032) Table 278. Latin America Human Interleukin ELISA Kit Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 279. Latin America Human Interleukin ELISA Kit Sales by Country (2021-2026) & (k units) Table 280. Latin America Human Interleukin ELISA Kit Sales Market Share by Country (2021-2026) Table 281. Latin America Human Interleukin ELISA Kit Sales Forecast by Country (2027-2032) & (k units) Table 282. Latin America Human Interleukin ELISA Kit Sales Market Share Forecast by Country (2027-2032) Table 283. Latin America Human Interleukin ELISA Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 284. Latin America Human Interleukin ELISA Kit Market Size by Country (2021-2026) & (US$ Million) Table 285. Latin America Human Interleukin ELISA Kit Market Share by Country (2021-2026) Table 286. Latin America Human Interleukin ELISA Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 287. Latin America Human Interleukin ELISA Kit Market Share Forecast by Country (2027-2032) Table 288. Middle East and Africa Human Interleukin ELISA Kit Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 289. Middle East and Africa Human Interleukin ELISA Kit Sales by Country (2021-2026) & (k units) Table 290. Middle East and Africa Human Interleukin ELISA Kit Sales Market Share by Country (2021-2026) Table 291. Middle East and Africa Human Interleukin ELISA Kit Sales Forecast by Country (2027-2032) & (k units) Table 292. Middle East and Africa Human Interleukin ELISA Kit Sales Market Share Forecast by Country (2027-2032) Table 293. Middle East and Africa Human Interleukin ELISA Kit Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 294. Middle East and Africa Human Interleukin ELISA Kit Market Size by Country (2021-2026) & (US$ Million) Table 295. Middle East and Africa Human Interleukin ELISA Kit Market Share by Country (2021-2026) Table 296. Middle East and Africa Human Interleukin ELISA Kit Market Size Forecast by Country (2027-2032) & (US$ Million) Table 297. Middle East and Africa Human Interleukin ELISA Kit Market Share Forecast by Country (2027-2032) Table 298. Key Raw Materials Table 299. Raw Materials Key Suppliers Table 300. Human Interleukin ELISA Kit Distributors List Table 301. Human Interleukin ELISA Kit Customers List Table 302. Research Programs/Design for This Report Table 303. Authors List of This Report Table 304. Secondary Sources Table 305. Primary Sources List of Figures Figure 1. Human Interleukin ELISA Kit Image Figure 2. Global Human Interleukin ELISA Kit Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Human Interleukin ELISA Kit Market Size (2021-2032) & (US$ Million) Figure 4. Global Human Interleukin ELISA Kit Sales (2021-2032) & (k units) Figure 5. Sandwich ELISA Image Figure 6. Global Sandwich ELISA Sales YoY Growth (2021-2032) & (k units) Figure 7. Competitive ELISA Image Figure 8. Global Competitive ELISA Sales YoY Growth (2021-2032) & (k units) Figure 9. Direct ELISA Image Figure 10. Global Direct ELISA Sales YoY Growth (2021-2032) & (k units) Figure 11. Indirect ELISA Image Figure 12. Global Indirect ELISA Sales YoY Growth (2021-2032) & (k units) Figure 13. Global Human Interleukin ELISA Kit Market Size Overview by Type (2021-2032) & (US$ Million) Figure 14. Global Human Interleukin ELISA Kit Market Share by Type 2025 VS 2032 Figure 15. North America Human Interleukin ELISA Kit Sales Market Share in Volume by Type in 2025 Figure 16. North America Human Interleukin ELISA Kit Sales Market Share in Value by Type in 2025 Figure 17. Europe Human Interleukin ELISA Kit Sales Market Share in Volume by Type in 2025 Figure 18. Europe Human Interleukin ELISA Kit Sales Market Share in Value by Type in 2025 Figure 19. Asia-Pacific Human Interleukin ELISA Kit Sales Market Share in Volume by Type in 2025 Figure 20. Asia-Pacific Human Interleukin ELISA Kit Sales Market Share in Value by Type in 2025 Figure 21. Latin America Human Interleukin ELISA Kit Sales Market Share in Volume by Type in 2025 Figure 22. Latin America Human Interleukin ELISA Kit Sales Market Share in Value by Type in 2025 Figure 23. Middle East and Africa Human Interleukin ELISA Kit Sales Market Share in Volume by Type in 2025 Figure 24. Middle East and Africa Human Interleukin ELISA Kit Sales Market Share in Value by Type in 2025 Figure 25. Global Top 5 and 10 Human Interleukin ELISA Kit Players Market Share by Revenue in 2025 Figure 26. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Clinical Diagnosis Image Figure 28. Global Clinical Diagnosis Sales YoY Growth (2021-2032) & (k units) Figure 29. Drug Development Image Figure 30. Global Drug Development Sales YoY Growth (2021-2032) & (k units) Figure 31. Global Human Interleukin ELISA Kit Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Human Interleukin ELISA Kit Market Share by Application 2025 VS 2032 Figure 33. North America Human Interleukin ELISA Kit Sales Market Share in Volume by Application in 2025 Figure 34. North America Human Interleukin ELISA Kit Sales Market Share in Value by Application in 2025 Figure 35. Europe Human Interleukin ELISA Kit Sales Market Share in Volume by Application in 2025 Figure 36. Europe Human Interleukin ELISA Kit Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Human Interleukin ELISA Kit Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Human Interleukin ELISA Kit Sales Market Share in Value by Application in 2025 Figure 39. Latin America Human Interleukin ELISA Kit Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Human Interleukin ELISA Kit Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Human Interleukin ELISA Kit Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Human Interleukin ELISA Kit Sales Market Share in Value by Application in 2025 Figure 43. North America Human Interleukin ELISA Kit Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 44. North America Human Interleukin ELISA Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Human Interleukin ELISA Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Human Interleukin ELISA Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Human Interleukin ELISA Kit Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 48. Europe Human Interleukin ELISA Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Human Interleukin ELISA Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Human Interleukin ELISA Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Human Interleukin ELISA Kit Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 52. Asia-Pacific Human Interleukin ELISA Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Human Interleukin ELISA Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Human Interleukin ELISA Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Human Interleukin ELISA Kit Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 56. Latin America Human Interleukin ELISA Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Human Interleukin ELISA Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Human Interleukin ELISA Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Human Interleukin ELISA Kit Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 60. Middle East and Africa Human Interleukin ELISA Kit Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Human Interleukin ELISA Kit Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Human Interleukin ELISA Kit Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Human Interleukin ELISA Kit Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Human Interleukin ELISA Kit Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Sandwich ELISA
  • Competitive ELISA
  • Direct ELISA
  • Indirect ELISA
Applications
  • Clinical Diagnosis
  • Drug Development
Companies covered
  • Abcam
  • Mabtech AB
  • Aviva Systems Biology
  • G Biosciences
  • MD Bioproducts
  • OriGene Technologies
  • Eagle Bioscience
  • Novus Biologicals
  • Thermo Fisher Scientific
  • Enzo Life Sciences
  • BioLegend
  • DEMEDITEC Diagnostics
  • ScienCell Research Laboratories
  • Exreprotein
  • R&D Systems
  • Cell Sciences
  • AssayPro
  • BPS Bioscience
  • ACROBiosystems
  • Cayman Chemical
  • BosterBio
  • Bioassay Technology Laboratory
  • Kamiya Biomedical Company
  • Reddot Biotech
  • Krishgen Biosystems
  • RayBiotech
  • United States Biological
  • Sino Biological
  • CUSABIO Technology
  • Bioss
  • MyBioSource.com
  • BioVendor Laboratory Medicine
  • Abbexa
  • Fine Biotech
  • Biorbyt

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Human Interleukin ELISA Kit Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Human Interleukin ELISA Kit Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Human Interleukin ELISA Kit Market by Type
  6. 1.3.1 Sandwich ELISA
  7. 1.3.2 Competitive ELISA
  8. 1.3.3 Direct ELISA
  9. 1.3.4 Indirect ELISA
  10. 1.4 Global Human Interleukin ELISA Kit Market Size by Type
  11. 1.4.1 Global Human Interleukin ELISA Kit Market Size Overview by Type (2021-2032)
  12. 1.4.2 Global Human Interleukin ELISA Kit Historic Market Size Review by Type (2021-2026)
  13. 1.4.3 Global Human Interleukin ELISA Kit Forecasted Market Size by Type (2027-2032)
  14. 1.5 Key Regions Market Size by Type
  15. 1.5.1 North America Human Interleukin ELISA Kit Sales Breakdown by Type (2021-2026)
  16. 1.5.2 Europe Human Interleukin ELISA Kit Sales Breakdown by Type (2021-2026)
  17. 1.5.3 Asia-Pacific Human Interleukin ELISA Kit Sales Breakdown by Type (2021-2026)
  18. 1.5.4 South America Human Interleukin ELISA Kit Sales Breakdown by Type (2021-2026)
  19. 1.5.5 Middle East and Africa Human Interleukin ELISA Kit Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Human Interleukin ELISA Kit Industry Trends
  2. 2.2 Human Interleukin ELISA Kit Industry Drivers
  3. 2.3 Human Interleukin ELISA Kit Industry Opportunities and Challenges
  4. 2.4 Human Interleukin ELISA Kit Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Human Interleukin ELISA Kit Revenue (2021-2026)
  2. 3.2 Global Top Players by Human Interleukin ELISA Kit Sales (2021-2026)
  3. 3.3 Global Top Players by Human Interleukin ELISA Kit Price (2021-2026)
  4. 3.4 Global Human Interleukin ELISA Kit Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Human Interleukin ELISA Kit Major Company Production Sites & Headquarters
  6. 3.6 Global Human Interleukin ELISA Kit Company, Product Type & Application
  7. 3.7 Global Human Interleukin ELISA Kit Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Human Interleukin ELISA Kit Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Human Interleukin ELISA Kit Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Human Interleukin ELISA Kit Tier 1, Tier 2, and Tier 3
4 Human Interleukin ELISA Kit Regional Status and Outlook
  1. 4.1 Global Human Interleukin ELISA Kit Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Human Interleukin ELISA Kit Historic Market Size by Region
  3. 4.2.1 Global Human Interleukin ELISA Kit Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Human Interleukin ELISA Kit Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Human Interleukin ELISA Kit Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Human Interleukin ELISA Kit Forecasted Market Size by Region
  7. 4.3.1 Global Human Interleukin ELISA Kit Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Human Interleukin ELISA Kit Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Human Interleukin ELISA Kit Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Human Interleukin ELISA Kit by Application
  1. 5.1 Human Interleukin ELISA Kit Market by Application
  2. 5.1.1 Clinical Diagnosis
  3. 5.1.2 Drug Development
  4. 5.2 Global Human Interleukin ELISA Kit Market Size by Application
  5. 5.2.1 Global Human Interleukin ELISA Kit Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Human Interleukin ELISA Kit Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Human Interleukin ELISA Kit Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Human Interleukin ELISA Kit Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Human Interleukin ELISA Kit Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Human Interleukin ELISA Kit Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Human Interleukin ELISA Kit Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Human Interleukin ELISA Kit Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Abcam
  2. 6.1.1 Abcam Company Information
  3. 6.1.2 Abcam Business Overview
  4. 6.1.3 Abcam Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Abcam Human Interleukin ELISA Kit Product Portfolio
  6. 6.1.5 Abcam Recent Developments
  7. 6.2 Mabtech AB
  8. 6.2.1 Mabtech AB Company Information
  9. 6.2.2 Mabtech AB Business Overview
  10. 6.2.3 Mabtech AB Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Mabtech AB Human Interleukin ELISA Kit Product Portfolio
  12. 6.2.5 Mabtech AB Recent Developments
  13. 6.3 Aviva Systems Biology
  14. 6.3.1 Aviva Systems Biology Company Information
  15. 6.3.2 Aviva Systems Biology Business Overview
  16. 6.3.3 Aviva Systems Biology Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Aviva Systems Biology Human Interleukin ELISA Kit Product Portfolio
  18. 6.3.5 Aviva Systems Biology Recent Developments
  19. 6.4 G Biosciences
  20. 6.4.1 G Biosciences Company Information
  21. 6.4.2 G Biosciences Business Overview
  22. 6.4.3 G Biosciences Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 G Biosciences Human Interleukin ELISA Kit Product Portfolio
  24. 6.4.5 G Biosciences Recent Developments
  25. 6.5 MD Bioproducts
  26. 6.5.1 MD Bioproducts Company Information
  27. 6.5.2 MD Bioproducts Business Overview
  28. 6.5.3 MD Bioproducts Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 MD Bioproducts Human Interleukin ELISA Kit Product Portfolio
  30. 6.5.5 MD Bioproducts Recent Developments
  31. 6.6 OriGene Technologies
  32. 6.6.1 OriGene Technologies Company Information
  33. 6.6.2 OriGene Technologies Business Overview
  34. 6.6.3 OriGene Technologies Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 OriGene Technologies Human Interleukin ELISA Kit Product Portfolio
  36. 6.6.5 OriGene Technologies Recent Developments
  37. 6.7 Eagle Bioscience
  38. 6.7.1 Eagle Bioscience Company Information
  39. 6.7.2 Eagle Bioscience Business Overview
  40. 6.7.3 Eagle Bioscience Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Eagle Bioscience Human Interleukin ELISA Kit Product Portfolio
  42. 6.7.5 Eagle Bioscience Recent Developments
  43. 6.8 Novus Biologicals
  44. 6.8.1 Novus Biologicals Company Information
  45. 6.8.2 Novus Biologicals Business Overview
  46. 6.8.3 Novus Biologicals Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Novus Biologicals Human Interleukin ELISA Kit Product Portfolio
  48. 6.8.5 Novus Biologicals Recent Developments
  49. 6.9 Thermo Fisher Scientific
  50. 6.9.1 Thermo Fisher Scientific Company Information
  51. 6.9.2 Thermo Fisher Scientific Business Overview
  52. 6.9.3 Thermo Fisher Scientific Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Thermo Fisher Scientific Human Interleukin ELISA Kit Product Portfolio
  54. 6.9.5 Thermo Fisher Scientific Recent Developments
  55. 6.10 Enzo Life Sciences
  56. 6.10.1 Enzo Life Sciences Company Information
  57. 6.10.2 Enzo Life Sciences Business Overview
  58. 6.10.3 Enzo Life Sciences Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Enzo Life Sciences Human Interleukin ELISA Kit Product Portfolio
  60. 6.10.5 Enzo Life Sciences Recent Developments
  61. 6.11 BioLegend
  62. 6.11.1 BioLegend Company Information
  63. 6.11.2 BioLegend Business Overview
  64. 6.11.3 BioLegend Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 BioLegend Human Interleukin ELISA Kit Product Portfolio
  66. 6.11.5 BioLegend Recent Developments
  67. 6.12 DEMEDITEC Diagnostics
  68. 6.12.1 DEMEDITEC Diagnostics Company Information
  69. 6.12.2 DEMEDITEC Diagnostics Business Overview
  70. 6.12.3 DEMEDITEC Diagnostics Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 DEMEDITEC Diagnostics Human Interleukin ELISA Kit Product Portfolio
  72. 6.12.5 DEMEDITEC Diagnostics Recent Developments
  73. 6.13 ScienCell Research Laboratories
  74. 6.13.1 ScienCell Research Laboratories Company Information
  75. 6.13.2 ScienCell Research Laboratories Business Overview
  76. 6.13.3 ScienCell Research Laboratories Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 ScienCell Research Laboratories Human Interleukin ELISA Kit Product Portfolio
  78. 6.13.5 ScienCell Research Laboratories Recent Developments
  79. 6.14 Exreprotein
  80. 6.14.1 Exreprotein Company Information
  81. 6.14.2 Exreprotein Business Overview
  82. 6.14.3 Exreprotein Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Exreprotein Human Interleukin ELISA Kit Product Portfolio
  84. 6.14.5 Exreprotein Recent Developments
  85. 6.15 R&D Systems
  86. 6.15.1 R&D Systems Company Information
  87. 6.15.2 R&D Systems Business Overview
  88. 6.15.3 R&D Systems Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 R&D Systems Human Interleukin ELISA Kit Product Portfolio
  90. 6.15.5 R&D Systems Recent Developments
  91. 6.16 Cell Sciences
  92. 6.16.1 Cell Sciences Company Information
  93. 6.16.2 Cell Sciences Business Overview
  94. 6.16.3 Cell Sciences Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Cell Sciences Human Interleukin ELISA Kit Product Portfolio
  96. 6.16.5 Cell Sciences Recent Developments
  97. 6.17 AssayPro
  98. 6.17.1 AssayPro Company Information
  99. 6.17.2 AssayPro Business Overview
  100. 6.17.3 AssayPro Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 AssayPro Human Interleukin ELISA Kit Product Portfolio
  102. 6.17.5 AssayPro Recent Developments
  103. 6.18 BPS Bioscience
  104. 6.18.1 BPS Bioscience Company Information
  105. 6.18.2 BPS Bioscience Business Overview
  106. 6.18.3 BPS Bioscience Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  107. 6.18.4 BPS Bioscience Human Interleukin ELISA Kit Product Portfolio
  108. 6.18.5 BPS Bioscience Recent Developments
  109. 6.19 ACROBiosystems
  110. 6.19.1 ACROBiosystems Company Information
  111. 6.19.2 ACROBiosystems Business Overview
  112. 6.19.3 ACROBiosystems Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  113. 6.19.4 ACROBiosystems Human Interleukin ELISA Kit Product Portfolio
  114. 6.19.5 ACROBiosystems Recent Developments
  115. 6.20 Cayman Chemical
  116. 6.20.1 Cayman Chemical Company Information
  117. 6.20.2 Cayman Chemical Business Overview
  118. 6.20.3 Cayman Chemical Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  119. 6.20.4 Cayman Chemical Human Interleukin ELISA Kit Product Portfolio
  120. 6.20.5 Cayman Chemical Recent Developments
  121. 6.21 BosterBio
  122. 6.21.1 BosterBio Company Information
  123. 6.21.2 BosterBio Business Overview
  124. 6.21.3 BosterBio Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  125. 6.21.4 BosterBio Human Interleukin ELISA Kit Product Portfolio
  126. 6.21.5 BosterBio Recent Developments
  127. 6.22 Bioassay Technology Laboratory
  128. 6.22.1 Bioassay Technology Laboratory Company Information
  129. 6.22.2 Bioassay Technology Laboratory Business Overview
  130. 6.22.3 Bioassay Technology Laboratory Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  131. 6.22.4 Bioassay Technology Laboratory Human Interleukin ELISA Kit Product Portfolio
  132. 6.22.5 Bioassay Technology Laboratory Recent Developments
  133. 6.23 Kamiya Biomedical Company
  134. 6.23.1 Kamiya Biomedical Company Company Information
  135. 6.23.2 Kamiya Biomedical Company Business Overview
  136. 6.23.3 Kamiya Biomedical Company Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  137. 6.23.4 Kamiya Biomedical Company Human Interleukin ELISA Kit Product Portfolio
  138. 6.23.5 Kamiya Biomedical Company Recent Developments
  139. 6.24 Reddot Biotech
  140. 6.24.1 Reddot Biotech Company Information
  141. 6.24.2 Reddot Biotech Business Overview
  142. 6.24.3 Reddot Biotech Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  143. 6.24.4 Reddot Biotech Human Interleukin ELISA Kit Product Portfolio
  144. 6.24.5 Reddot Biotech Recent Developments
  145. 6.25 Krishgen Biosystems
  146. 6.25.1 Krishgen Biosystems Company Information
  147. 6.25.2 Krishgen Biosystems Business Overview
  148. 6.25.3 Krishgen Biosystems Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  149. 6.25.4 Krishgen Biosystems Human Interleukin ELISA Kit Product Portfolio
  150. 6.25.5 Krishgen Biosystems Recent Developments
  151. 6.26 RayBiotech
  152. 6.26.1 RayBiotech Company Information
  153. 6.26.2 RayBiotech Business Overview
  154. 6.26.3 RayBiotech Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  155. 6.26.4 RayBiotech Human Interleukin ELISA Kit Product Portfolio
  156. 6.26.5 RayBiotech Recent Developments
  157. 6.27 United States Biological
  158. 6.27.1 United States Biological Company Information
  159. 6.27.2 United States Biological Business Overview
  160. 6.27.3 United States Biological Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  161. 6.27.4 United States Biological Human Interleukin ELISA Kit Product Portfolio
  162. 6.27.5 United States Biological Recent Developments
  163. 6.28 Sino Biological
  164. 6.28.1 Sino Biological Company Information
  165. 6.28.2 Sino Biological Business Overview
  166. 6.28.3 Sino Biological Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  167. 6.28.4 Sino Biological Human Interleukin ELISA Kit Product Portfolio
  168. 6.28.5 Sino Biological Recent Developments
  169. 6.29 CUSABIO Technology
  170. 6.29.1 CUSABIO Technology Company Information
  171. 6.29.2 CUSABIO Technology Business Overview
  172. 6.29.3 CUSABIO Technology Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  173. 6.29.4 CUSABIO Technology Human Interleukin ELISA Kit Product Portfolio
  174. 6.29.5 CUSABIO Technology Recent Developments
  175. 6.30 Bioss
  176. 6.30.1 Bioss Company Information
  177. 6.30.2 Bioss Business Overview
  178. 6.30.3 Bioss Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  179. 6.30.4 Bioss Human Interleukin ELISA Kit Product Portfolio
  180. 6.30.5 Bioss Recent Developments
  181. 6.31 MyBioSource.com
  182. 6.31.1 MyBioSource.com Company Information
  183. 6.31.2 MyBioSource.com Business Overview
  184. 6.31.3 MyBioSource.com Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  185. 6.31.4 MyBioSource.com Human Interleukin ELISA Kit Product Portfolio
  186. 6.31.5 MyBioSource.com Recent Developments
  187. 6.32 BioVendor Laboratory Medicine
  188. 6.32.1 BioVendor Laboratory Medicine Company Information
  189. 6.32.2 BioVendor Laboratory Medicine Business Overview
  190. 6.32.3 BioVendor Laboratory Medicine Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  191. 6.32.4 BioVendor Laboratory Medicine Human Interleukin ELISA Kit Product Portfolio
  192. 6.32.5 BioVendor Laboratory Medicine Recent Developments
  193. 6.33 Abbexa
  194. 6.33.1 Abbexa Company Information
  195. 6.33.2 Abbexa Business Overview
  196. 6.33.3 Abbexa Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  197. 6.33.4 Abbexa Human Interleukin ELISA Kit Product Portfolio
  198. 6.33.5 Abbexa Recent Developments
  199. 6.34 Fine Biotech
  200. 6.34.1 Fine Biotech Company Information
  201. 6.34.2 Fine Biotech Business Overview
  202. 6.34.3 Fine Biotech Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  203. 6.34.4 Fine Biotech Human Interleukin ELISA Kit Product Portfolio
  204. 6.34.5 Fine Biotech Recent Developments
  205. 6.35 Biorbyt
  206. 6.35.1 Biorbyt Company Information
  207. 6.35.2 Biorbyt Business Overview
  208. 6.35.3 Biorbyt Human Interleukin ELISA Kit Sales, Revenue and Gross Margin (2021-2026)
  209. 6.35.4 Biorbyt Human Interleukin ELISA Kit Product Portfolio
  210. 6.35.5 Biorbyt Recent Developments
7 North America by Country
  1. 7.1 North America Human Interleukin ELISA Kit Sales by Country
  2. 7.1.1 North America Human Interleukin ELISA Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Human Interleukin ELISA Kit Sales by Country (2021-2026)
  4. 7.1.3 North America Human Interleukin ELISA Kit Sales Forecast by Country (2027-2032)
  5. 7.2 North America Human Interleukin ELISA Kit Market Size by Country
  6. 7.2.1 North America Human Interleukin ELISA Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Human Interleukin ELISA Kit Market Size by Country (2021-2026)
  8. 7.2.3 North America Human Interleukin ELISA Kit Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Human Interleukin ELISA Kit Sales by Country
  2. 8.1.1 Europe Human Interleukin ELISA Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Human Interleukin ELISA Kit Sales by Country (2021-2026)
  4. 8.1.3 Europe Human Interleukin ELISA Kit Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Human Interleukin ELISA Kit Market Size by Country
  6. 8.2.1 Europe Human Interleukin ELISA Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Human Interleukin ELISA Kit Market Size by Country (2021-2026)
  8. 8.2.3 Europe Human Interleukin ELISA Kit Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Human Interleukin ELISA Kit Sales by Country
  2. 9.1.1 Asia-Pacific Human Interleukin ELISA Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Human Interleukin ELISA Kit Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Human Interleukin ELISA Kit Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Human Interleukin ELISA Kit Market Size by Country
  6. 9.2.1 Asia-Pacific Human Interleukin ELISA Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Human Interleukin ELISA Kit Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Human Interleukin ELISA Kit Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Human Interleukin ELISA Kit Sales by Country
  2. 10.1.1 South America Human Interleukin ELISA Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Human Interleukin ELISA Kit Sales by Country (2021-2026)
  4. 10.1.3 South America Human Interleukin ELISA Kit Sales Forecast by Country (2027-2032)
  5. 10.2 South America Human Interleukin ELISA Kit Market Size by Country
  6. 10.2.1 South America Human Interleukin ELISA Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Human Interleukin ELISA Kit Market Size by Country (2021-2026)
  8. 10.2.3 South America Human Interleukin ELISA Kit Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Human Interleukin ELISA Kit Sales by Country
  2. 11.1.1 Middle East and Africa Human Interleukin ELISA Kit Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Human Interleukin ELISA Kit Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Human Interleukin ELISA Kit Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Human Interleukin ELISA Kit Market Size by Country
  6. 11.2.1 Middle East and Africa Human Interleukin ELISA Kit Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Human Interleukin ELISA Kit Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Human Interleukin ELISA Kit Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Human Interleukin ELISA Kit Value Chain Analysis
  2. 12.1.1 Human Interleukin ELISA Kit Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Human Interleukin ELISA Kit Production Mode & Process
  7. 12.2 Human Interleukin ELISA Kit Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Human Interleukin ELISA Kit Distributors
  10. 12.2.3 Human Interleukin ELISA Kit Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst